II. Pathophysiology
- See HIV Pathophysiology
- HIV is associated with several categories of complications
- Direct HIV Infection related symptoms and effects
- Immunodefiency
- Significantly reduced with modern Antiretroviral therapy
- Malignancy
- Opportunistic infections
- Persistent immune activation and chronic inflammation
- Persists despite modern Antiretroviral therapy
III. Complications
-
Cardiovascular Manifestations of HIV
- See Cardiovascular Manifestations of HIV
- HIV Cardiomyopathy
- HIV and specific ART agents are considered Cardiovascular Risk Factors
- Cardiovascular Disease
- Dyslipidemia
- Dermatologic Manifestations of HIV
- Eye Manifestations
- Endocrine Manifestations of HIV
- Gastrointestinal Manifestations of HIV
- Head and neck manifestations of HIV
- Hematologic Manifestations of HIV
- Lymphadenopathy in HIV
-
Malignancy in HIV
- HIV related Lymphoma (B Cell Lymphoma)
- Kaposi Sarcoma
- HPV related coinfections (Cervical Cancer, Anal Cancer)
- Neurologic Manifestations of HIV
- Renal Manifestations of HIV
- Opportunistic Infections in HIV
- Pulmonary Manifestations of HIV
- Rheumatologic Manifestations of HIV
- Sexual Health
IV. Prevention
- Lifestyle modification
- Tobacco Cessation
- Substance Use Disorder screening
- Exercise
- Healthy Diet
- Update Vaccinations
- Cancer Screening
- Follow USPTF and ACS guidelines for other cancers based on age, gender and non-HIV Risk Factors
- Anal Cancer
- Offer HPV Vaccine up to age 45 years
- Digital Rectal Exam AND Anal cytology or high risk HPV Testing
- High resolution Anoscopy if positive results
- Indications
- Age >=45 years OR
- Age >= 35 years
- Cervical Cancer
- See Cervical Cancer Screening
- Offer HPV Vaccine up to age 45 years
- Continue Cervical Cancer Screening lifelong in HIV (do not stop in Menopause)
- Hepatocellular Carcinoma
- Screening indicated in Cirrhosis and some Hepatitis B and Hepatitis CVirus infections
- HIV Monitoring
- See Antiretroviral therapy
- Plasma HIV Viral Load
- Initially every 1-2 months after starting ART, then every 3-4 months for 1 year, then every 6 months
- CD4 Cell Count
- Obtained at baseline, every 3-6 months for 2 years, then optional if >500 cells/uL AND suppressed >2 years
- HIV genotypic assay
- Obtained baseline and then as needed (e.g. inconsistent ART, suspected ART resistance)
- Infection Screening
- Viral Hepatitis (baseline and then as indicated)
- Sexually Transmitted Infection (baseline and then yearly as indicated)
- Syphilis IgG and RPR
- Recheck post-treatment for 2 years (month 3, 6, 9, 12 and 24 months)
- PCR (Nucleic Acid amplification) of all exposed sites (urine, rectal, oropharyngeal)
- Trichomoniasis PCR
- Syphilis IgG and RPR
- Recurrent Cervicitis or Urethritis
- Consider testing and treating for Mycoplasma Genitalium or Ureaplasma Urealyticum
- Both respond to Doxycycline 100 mg orally or IV every 12 hours for 7 to 14 days
- Tuberculosis
- Tuberculin Skin Test or IFN-Gamma Release Assay (e.g. Quantiferon) baseline and then yearly as needed
- Metabolic Disorders
- Fasting Glucose
- Obtain baseline and then yearly as needed (most patients)
- Lipid profile
- Obtain baseline and then yearly as needed (may space to every 5 years if consistently normal)
- Comprehensive metabolic panel
- Obtain at baseline, 1-2 months after starting ART, then every 6 months
- Includes eGFR (based on Serum Creatinine or cystatin-C)
- Urinalysis
- Assess for Proteinuria, Hematuria and Crystalluria
- Complete Blood Count with differential and Platelet Count
- Obtain baseline and then every year
- Osteoporosis Screening
- Osteoporosis Risk Assessment
- Obtain baseline DEXA Scan in men age >50 years and postmenopausal women
- Fasting Glucose